IL6 and type 2 diabetes mellitus: Supplementation also decreases inflammatory gene expression, particularly of IL-6, IL-10, and IFN-γ, which serves as a potential benefit in protecting against T2DM development and disease progression through their roles in influencing platelet-mediated inflammation [229,230].